Cliantha Research spearheads clinical study as growing evidence and investor enthusiasm converge around inflammation-based innovation.

HUNTINGTON, N.Y., July 25, 2025 — Sen-Jam Pharmaceutical has initiated a Phase 2 clinical trial for its pioneering hangover prevention therapy, SJP-001, now underway in Canada with global research partner Cliantha. This milestone positions SJP-001 to become the first FDA therapy to directly target the inflammatory root cause of alcohol-induced symptoms—moving beyond surface-level relief like hydration. It also represents a flagship validation of Sen-Jam’s PAIR Technology (Preemptive Anti-Inflammatory Regulators) platform—a scalable, modular technology designed to unlock next-generation broad spectrum anti-inflammatory therapies for a wide range of inflammation-driven conditions with massive unmet needs.

Amid increasing global scrutiny of alcohol’s long-term health risks, SJP-001 arrives at a pivotal moment. In January 2025, the U.S. Surgeon General issued a stark warning linking chronic alcohol consumption to increased cancer risk, citing systemic inflammation as a major driver—a warning that echoes the scientific foundation of Sen-Jam’s therapeutic approach. 

“We’re not only addressing the acute discomfort of the morning after,“ said Jackie Iversen, RPh, MS, Co-Founder and Chief Clinical Officer at Sen-Jam. “We’re contributing to the global response to alcohol-related inflammation and long-term health implications.”

“At Desire Ventures, we back companies that combine purpose and performance. Supporting a Canadian-led clinical program with worldwide implications makes Sen-Jam a natural fit,” said Assad S. Aslam, Managing Partner of Desire Ventures, an investor in the program.

Sen-Jam’s peer-reviewed publication from January 2025 further elaborates on this connection, reinforcing the need for innovation specifically targeting inflammatory responses:
  Read: Alcohol Use, Inflammation, and Cancer Risk

Inflammation is the Mechanism. SJP-001 is the Solution. And the Market is Ripe for a Leader.

SJP-001 is protected by 23 global patents and built on a novel combination of repurposed drugs designed to safely disrupt the inflammatory cascade triggered by alcohol consumption. Unlike surface-level remedies, SJP-001 targets the biological driver of hangover symptoms—offering a scientifically grounded, first-in-class approach.

A published pilot study has already shown significant reductions in both the severity and duration of symptoms, confirming the compound’s early efficacy:
  Pilot Study of SJP-001 – PubMed

Further reinforcing this approach, Dr. Joris Verster—widely regarded as the father of alcohol hangover research—has recently published a comprehensive review of existing remedies underscoring the importance of inflammation-targeted interventions. His analysis validates anti-inflammatory mechanisms as the most promising route for future therapies:
  Verster 2024 Review – Journal of Translational Medicine

“Our innovation is about more than relief—it’s about resilience, well-being, and protecting people who choose to consume alcohol socially,” continued Iversen. “According to the World Health Organization, that’s approximately 2.4 billion people globally.”

And the global market is finally catching up to science. Grand View Research projects the hangover remedies market will grow at a 14.9% CAGR, reaching $6.2 billion by 2030—a category long dismissed as folklore now emerging as a credible, clinical frontier.

A Movement in Motion: Sen-Jam’s Community-Powered Model Attracts 1,100+ Investors Backing the Future of Preventive Pharma

The tides are turning in healthcare. As consumers demand more control over their well-being, and investors seek meaningful exposure to preventive, protective, and more elegant inflammation-targeted therapies, Sen-Jam is answering the call—with science, structure, and choice.

To give mission-aligned supporters maximum flexibility, Sen-Jam is offering three complementary ways to participate:

• Philanthropic Giving via CataCap
• Community Investing via Wefunder
• Reg D 506C – Contact Sen-Jam Directly

“We’re democratizing access to a market traditionally closed off to all but the largest players,” said Jim Iversen, CEO. “This is about more than raising capital. It’s about building a values-aligned community that’s invested in the future of health and in helping each other live healthier, longer lives.”

Sen-Jam has already attracted over 1,100 investors, with about 30% choosing to invest a second time—a signal of trust, traction, and shared belief in the company’s mission and model. If you’re interested in exploring their fundraising campaign, visit their Wefunder offer.

Interested parties are also invited to join Sen-Jam’s leadership for an exclusive deep dive into SJP-001’s market potential, the science behind it, and how you can participate in the journey. Next Wednesday, July 30th at 1pm EST. Registration for this event is required and can be secured here.

About Sen-Jam Pharmaceutical

Sen-Jam Pharmaceutical is a drug innovation company developing safe and efficacious therapies for some of the world’s most widespread and costly health challenges. By repurposing well-characterized small molecules through its proprietary delivery platform—and leveraging the FDA’s accelerated 505(b)(2) regulatory pathway—Sen-Jam is building a new class of anti-inflammatories designed to target the entire spectrum of inflammatory pathways, not just one or two like traditional blockbusters. This platform approach opens doors to faster clinical validation, broader indications, and therapies that are not only effective—but accessible, safe, and scalable. Investor information available at Wefunder. Learn more at www.sen-jam.com.

CONTACT INFORMATION:
Sen-Jam Pharmaceutical
Christine Leonard
[email protected]
781-913-1902

SOURCE Sen-Jam Pharmaceutical

SAN FRANCISCO, July 24, 2025 — Junipero Capital, venture capital firm focused on tactical investment strategies in the technology sector, today announced the successful liquidation of its latest investment vehicle. The vehicle, focused on leveraged options in public tech equities, delivered a gross return of 2.18x, a net return of 1.93x after fees, and an extraordinary IRR of 4,107.76%, all within a 2.5-month investment period.

This result reinforces Junipero Capital’s ability to generate venture-scale returns through concentrated, time-bound strategies. The firm’s first fund, Junipero Fund I, which is now fully liquidated, produced a gross MOIC of 4.62x, DPI of 3.47x, and a 44.17% IRR over five years (March 2017 – March 2022), outperforming both the S&P 500 and NASDAQ.

“Delivering a near-2x net return in under three months reflects not only our rigorous research and execution discipline, but also the growing relevance of flexible, high-leverage strategies in public markets,” said Ignacio Vilela, Managing Partner at Junipero Capital. “We believe the traditional boundaries between public and private tech investing are blurring — and that creates opportunities for managers who can move decisively.”

Junipero Fund I deployed capital across 17 companies in 8 technology sectors, resulting in 9 IPOs, 7 secondary sales, and 1 acquisition. Notable investments included Okta, Coinbase, DocuSign, Zscaler, and Robinhood.

Through its various vehicles, Junipero Capital has previously invested in a number of leading technology companies, including Scale AI, Groq, CoreWeave, Notion, Blockdaemon, Stripe, and SpaceX.

Junipero Capital currently manages over $50 million in assets from a diversified base of private and institutional investors.

Disclaimer: This press release is for informational purposes only and does not constitute an offer to sell or a solicitation of an offer to buy any securities or investment products. Junipero Capital does not currently have any open investment offerings and is not soliciting capital through this communication.

SOURCE Junipero Capital

With this new funding, Armada will scale production of Leviathan, a first-of-its-kind, megawatt-scale, full-stack modular data center (MDC) that can be deployed faster, cheaper, and more flexibly than any other similar product in the field.

SAN FRANCISCO, July 24, 2025 — Armada, the hyperscaler for the edge, today announced a $131 million strategic funding round with new strategic investors including Pinegrove, Veriten, and Glade Brook as well as participation from existing investors including Founders Fund, Lux Capital, Shield Capital, 8090 Industries, M12 (Microsoft’s Venture Fund), Overmatch, Silent Ventures, Felicis, and Marlinspike. This latest investment round coincides with the launch of Leviathan, a first-of-its-kind ruggedized MDC designed for fast, flexible deployment, enabling megawatt-scale computing power in the world’s most contested and communications-challenged areas. With Leviathan, Armada is taking a major step to advance American leadership in energy and AI through an alternative approach that enables distributed AI training and inference. Leviathan joins the Galleon product line and offers 10x more compute power than Armada’s next-largest form factor.

“American energy and AI dominance hinges on one thing: moving massive compute to the edge—fast—where data and low-cost power live,” said Dan Wright, Co-Founder and CEO of Armada. “Leviathan, the newest member of our Galleon product line, does exactly that. Each unit delivers megawatt-scale performance in a fraction of the time and much more flexibly than traditional data centers, due to their ability to rapidly adapt to changes in AI chips and cooling, and co-locate with all available land and energy, regardless of its form or location. This latest product launch and funding further accelerate our mission to bridge the digital divide and ensure that the world runs on the American AI stack.”

Leviathan, the larger counterpart to Armada’s Triton data center in the Galleon product line, has ten times the amount of compute capacity at megawatt scale. Powered by the Armada Edge Platform (AEP), Leviathan delivers autonomous compute and real-world AI with speed, resilience, and reliability. Leviathan is adaptable to customer requirements, designed for scalability with the ability to relocate between locations and markets as customer requirements evolve. Deployable in remote, mission-critical environments, Leviathan can be co-located with stranded natural gas, solar, nuclear, or other alternative energy sources. It can be operational in weeks, eliminating traditional data centers’ long timelines and site limitations. As China ramps up efforts to export its AI stack and races to control the compute and energy supply chains of the future, the U.S. and its allies must move faster. Leviathan gives America the infrastructure advantage—modular, sovereign, and ready to deploy—so the U.S. can lead not just in AI development, but in the physical systems that power it. Leviathan enables AI-era dominance by delivering rapid compute power without the heavy infrastructure demands of traditional data centers.

“From day one, we backed Armada because they saw what others missed: America’s AI leadership hinges on owning the entire stack—from power and silicon to software—and being able to deploy it anywhere,” said Trae’ Stephens, Partner at Founders Fund and early Armada backer. “Leviathan drives that vision forward, expanding the Galleon lineup from suitcase-sized edge nodes for lightweight analytics and inference to megawatt-scale modules that can train and serve frontier models in the harshest environments. With a Galleon for every workload, Armada keeps U.S. and allied AI efforts a step ahead.”

The launch advances Armada’s broader vision for distributed, sovereign AI infrastructure, as outlined in a recent white paper detailing the need to tightly couple energy and compute to sustain U.S. leadership in the global AI race. Armada is partnering with organizations such as Fidelis New Energy and Bakken Energy to deploy Leviathans in strategic locations across the U.S. and allied territories—including North Dakota, Texas, West Virginia, and Louisiana—where surplus power can be converted into high-density compute.

“Leviathan embodies our belief that hardware should behave like software: deployable, upgradeable, and governed entirely by code,” said Pradeep Nair, Founding CTO of Armada. “Paired with the turnkey Armada Edge Platform and its growing Marketplace of AI models and applications, Leviathan’s liquid-cooled, energy-agnostic modules deliver megawatt-scale training and inference in weeks—bridging the digital divide by bringing AI straight to the edge, where data and power already live.”

For more on this launch, read the Founders’ Blog.

About Armada
Armada is a full-stack edge infrastructure company delivering compute, storage, connectivity, and AI/ML capabilities to the most remote and rugged industrial environments on Earth. From energy to defense, Armada enables organizations to operate at the edge—without compromise.

Media contact: [email protected]

SOURCE Armada

Backed by Charge VC, Inspired Capital, Red Swan Ventures, and Prospeq, Queen One is building performance and presence for all brands.

BROOKLYN, N.Y., July 24, 2025 — Queen One, a powerful brand technology platform that brings life, energy, and revenue to websites and communication portals, announced today that it has raised more than $5.5 million in a Friends & Family funding round. The round was led by operator-backed funds Charge VC, Inspired Capital, Red Swan Ventures, and Prospeq, alongside a group of entrepreneurs, past collaborators, and close supporters.

At the heart of Queen One is a simple, powerful belief: every product has a story. Not just how it was made—but how it’s used, loved, and shared. In a world where products are often reduced to SKUs and data points, Queen One sees them as goods. And when goods are at their best, they vibrate. They connect.

“Commerce has been stuck in the past. Queen One is pushing it forward — fast,” said Brett Martin, Managing Partner at Charge VC. “What Figma unlocked for designers, Queen One is now unlocking for brands. They’re turning static pages into living, breathing experiences. And they’re doing it with unmatched creativity, momentum, and care — for brands and for people.”

“From our very first conversation, it was clear that Queen One was building something special,” said Kamran Ali, Principal at Inspired Capital. “The founding team brings unmatched experience, clarity, and ambition — with a track record of scaling hypergrowth businesses while building best-in-class culture. Reimagining how people experience commerce is a bold and timely mission, and Queen One is the team to lead it. We’re thrilled to be on this journey with them.”

Queen One has already built powerful brand technology and released their first offering, Connect (powered by Dragon Tiles), secured $6 million in state support for job creation and long-term economic impact in New York, and scaled to a team of 33. Construction is underway on the Rise & Fly Vision Centre — a 30,000 sq. ft. Brooklyn headquarters designed to accelerate product development, brand growth, and cultural momentum.

“The Time is Now. New York is rising,” said Ryan Urban, CEO and Founder of Queen One. “I can’t think of a better place to build a worldscale company. Queen One is New York – you’ll start to see, hear, and feel our presence. Coming to a neighborhood near you.”

Sandy Cass, Managing Partner at Red Swan Ventures added, “Queen One is the kind of company we get excited about — bold vision, experienced operators, and palpable energy. They’re not iterating on the past — they’re architecting the future of commerce. We’re proud to support this founding team as they bring performance and presence to every brand online.”

“We’re a company built by builders and we know what it takes to work hard and ship big,” said Maricor Resente, COO and Founder. “Together with our investors, we’re ready to show the world what’s possible when you combine relentless execution with a clear vision. We can’t wait to deliver immense value to every brand globally – get ready to see what the best looks like.”

To stay connected with the Queen One team and learn more about what’s next, visit queen.one.

SOURCE Queen One

The investment, one of the largest in Utah this year, will help further HeroDevs’ commitment to securing legacy software applications, ensuring enterprise technology infrastructure remains compliant and protected

HeroDevs will dedicate $20 million of capital towards the HeroDevs Open Source Sustainability Fund to support open source creators, maintainers, and projects that follow end-of-life best practices.

SALT LAKE CITY, July 24, 2025 — HeroDevs, a leading provider of security and compliance solutions for deprecated open source software (OSS), today announced it has secured a $125 million strategic growth investment from PSG, a leading growth equity firm that specializes in partnering with software and technology-enabled services companies to capitalize on transformational growth. Existing investor Album also participated in the growth investment round.

Rapid AI adoption is accelerating the proliferation of OSS in enterprise security stacks — the average commercial codebase includes 911 open source components – and with this proliferation, 86% of those codebases contained OSS with known vulnerabilities, according to Black Duck. A separate report from Qualys found 48% of vulnerabilities stem from known vulnerabilities in OSS that are no longer supported or maintained.

This investment will help HeroDevs secure enterprise security stacks against these threats by strengthening its Never-Ending Support solutions, which help provide seamless and secure replacements for vulnerable unsupported or outdated OSS versions. By enabling enterprises to protect their infrastructure without overhauling entire applications, HeroDevs helps protect against vulnerabilities that often lead to data breaches and cyberattacks, while giving teams the flexibility to plan secure software transitions on their own timeline.

“In our view, open source software runs the world. Through this investment, we’re doubling down on our mission of ensuring everyone—from developers to startups to enterprises and governments—has the tools and support to stay safe and compliant, even when they find themselves stuck running end-of-life open source software,” said Aaron Frost, Founder and CEO of HeroDevs. “We believe that the lifeline we provide to our customers saves them thousands of hours and hundreds of millions of dollars, not to mention the loss in trust that comes from security breaches. Our team is proud to use this investment to solve two of the biggest challenges we face in the open source software community: funding the next generation of open source development and improving visibility around end-of-life security risks.”

“The acceleration of the adoption of open source software across enterprises highlights the growing demand for solutions that not only help companies meet strict security and compliance standards but also aim to preserve and strengthen the value of the broader open source ecosystem,” commented Marco Ferrari, Managing Director and Co-Head of North America, and Paul Russ, Principal, at PSG. “We believe the platform Aaron and the HeroDevs team have built empowers enterprises to secure vulnerable areas of software applications’ code without disrupting operations, while also fostering continued innovation across the open source community.”

HeroDevs will also dedicate $20 million of capital towards its Open Source Sustainability Fund to support open source creators, maintainers, and projects that follow end-of-life best practices. The Open Source Sustainability Fund is officially open and accepting applications. Developers and projects can now apply for the donations, ranging from $2,500 to $250,000. To be accepted, applicants must demonstrate strong community adoption, commit to following security best practices when announcing and conducting end-of-life motions for versions of their software, and agree to the program’s requirements. To apply for funding and learn more about the program, visit herodevs.com/sustainability-fund.

The Sustainability Fund builds on HeroDevs’ legacy of providing new funding models for the open source community. The company donates a portion of its revenue to open source creators and projects, including $4 million to date, and $2 million in 2024.

D.A. Davidson and Ampleo served as financial advisors to HeroDevs, and Foley & Lardner LLP served as legal advisor to HeroDevs. Weil, Gotshal & Manges LLP served as legal advisor to PSG.

About HeroDevs
HeroDevs is a trusted leader in providing secure, never-ending support for deprecated open-source software. The company’s mission is to keep these critical technologies running smoothly, securely, and in compliance long after their official end-of-life. From AngularJS to .NET and Spring, HeroDevs Never-Ending Support (NES) solutions give businesses the freedom to plan migrations on their terms while staying protected against vulnerabilities and compliance risks.

Serving industries where security and uptime are non-negotiable, including finance, healthcare, and government, HeroDevs has earned the trust of over 800 companies, including nearly a third of the Fortune 100. With a team of open-source experts, proactive vulnerability remediation, and enterprise-grade support, HeroDevs empowers organizations to keep moving forward without disruption.

About PSG
PSG is a growth equity firm that partners with software and technology-enabled services companies to help them navigate transformational growth, capitalize on strategic opportunities, and build strong teams. Having backed more than 150 companies and facilitated over 520 add-on acquisitions, PSG brings extensive investment experience, deep expertise in software and technology, and a firm commitment to collaborating with management teams. Founded in 2014, PSG operates out of offices in Boston, Kansas City, London, Madrid, Paris, and Tel-Aviv. To learn more about PSG, visit www.psgequity.com.

SOURCE HeroDevs

VANCOUVER, BC, July 24, 2025 — Bitzero, the company redefining sustainable Blockchain and High-Performance Compute (HPC) data centers, today announced it has secured $25 million in funding to drive immediate revenue growth and further its mission of setting a new global standard for clean, community-centered mining operations. The investment marks a major step forward in Bitzero’s commitment to transforming cryptocurrency‘s energy reputation, while delivering strong returns for investors.

The first drawdown of the funding will be allocated to the purchase of 2,900 Bitmain S21 Pro miners, one of the most advanced machines available, operating at an industry-leading 15 joules per terahash. Deployment of this high-efficiency hardware will be completed within four to six months, generating an estimated $10 million in additional annual revenue and driving Bitzero’s market-leading breakeven point even lower.

This funding arrives as Bitzero’s innovative approach to sustainable mining has already proven successful in Europe, positioning the company to capitalize on the booming cryptocurrency market, while addressing its environmental challenges head-on.

“Our mission has always been to prove that Blockchain infrastructure can thrive in harmony with investors, communities, and the environment,” said Bitzero’s President and CEO Mohammed Bakhashwain. “This new funding allows us to build on our success, accelerate deployment of best-in-class mining technology, and extend our leadership in sustainable, profitable data centers.”

Amid growing excitement around the cryptocurrency market — and rising concerns about its energy footprint — Bitzero stands apart with a proven, future-ready approach. Its Namsskogan data center in Norway runs entirely on hydropower.

Bitzero’s momentum underscores its position at the forefront of a new era in digital asset infrastructure, where renewable energy and community partnership come together to deliver financial value for stakeholders and environmental stewardship.

About Bitzero
Bitzero Blockchain Inc. is an ESG-focused provider of IT energy infrastructure and sustainable power generation for data centers. Headquartered in Vancouver, BC, the company owns and operates facilities in North America and Europe, supporting high-performance compute and blockchain workloads using hydroelectric and low-carbon energy sources. Visit www.bitzero.com for more information.

Media Contact:
[email protected] 

SOURCE Bitzero

Funding will accelerate expansion of AI-powered audience tools, contextual quality scoring, and premium demand curation solutions

NEW YORK, July 23, 2025 — ArcSpan, the leading publisher-first audience monetization platform, today announced it has raised $5.2 million in a Seed Extension round. The capital will support ArcSpan’s mission to help digital publishers maximize revenue by transforming first-party data into high-performance, advertiser-ready audience and curation solutions.

The funding round, backed by both new and existing investors, underscores growing demand for publisher-centric data platforms that deliver actionable audience segmentation, content intelligence, and direct monetization tools as the industry transitions beyond third-party cookies.

“Publishers are sitting on powerful audience signals but lack the tools to efficiently activate and monetize them,” said Art Muldoon, Co-Founder and CEO of ArcSpan. “This investment enables us to fast-track our AI development and scale new capabilities like contextual quality scoring, audience curation, and turnkey PMP activation, all while putting publisher control at the center.”

ArcSpan will use the funding to accelerate development and go-to-market efforts for several new innovations:

• Audience Builder 3.0 – AI-powered segmentation and modeling engine for real-time, agentic audiences
• PMP Activation Hub – pre-qualified publisher deal packaging and campaign enablement with SSP and DSP integrations
• ArcSpan QualityCloud^™ and AQI – contextual and ad placement quality scoring for inventory curation, planning, and optimization

Since launching the ArcSpan AMS enterprise data platform in 2023, ArcSpan has partnered with leading media companies and SSPs to streamline the path from data to demand. The AMS platform’s Triple-A Framework – Aggregation, Amplification, and Activation – gives publishers a simplified yet powerful approach to harnessing first-party data and driving premium yield.

“We believe ArcSpan is solving one of the most pressing problems in digital media – how to enable scalable, high-fidelity targeting and monetization of publisher audiences and first-party data signals for advertiser outcomes,” said Al Muzaurieta, Co-Founder at Good Apple. “Their vision, expertise, and traction in the market made this a compelling investment.”

With this raise, ArcSpan plans to expand its product, data science, and publisher success teams while deepening integrations across the advertising ecosystem.

To learn more about ArcSpan or to explore partnership opportunities, visit www.arcspan.com.

About ArcSpan

ArcSpan is an AI-powered audience monetization platform built for premium publishers. Through its Audience Monetization System (AMS), ArcSpan builds stronger data signals, activation outcomes, and comprehensive programmatic analytics to unlock the full value of their first-party audience data. Headquarted in NYC, with an office in London, ArcSpan partners with digital media leaders to drive performance, transparency, and control across the programmatic landscape.

SOURCE ArcSpan Technologies

Company Plans to Accelerate Development of Data Center Campuses and AI Infrastructure to Establish a Leading Digital AI Infrastructure Provider

MONTREAL and NEW YORK, July 23, 2025 — (version française) — 5C, a next-generation AI infrastructure and data center solutions provider, today announced it has successfully secured $835 million of capital to fuel its rapid growth. The funding includes equity financing led by Brookfield Asset Management and debt financing led by Deutsche Bank. 

Brookfield is investing through its Infrastructure Structured Solutions strategy, alongside affiliated entities. This capital will accelerate the development of 5C’s state-of-the-art data centers and scalable AI infrastructure across North America, addressing the rapidly growing demand for AI compute capacity and digital infrastructure. The company’s ability to quickly and reliably deploy AI infrastructure has positioned it as a key player in the AI ecosystem.

5C designs, develops, and operates advanced data centers and AI compute infrastructure purpose-built at scale for AI training, fine-tuning, and inference workloads. The company has rapidly emerged as a market leader in providing data centers tailored for the latest generation of liquid-cooled GPU clusters, offering comprehensive AI infrastructure solutions for neo-clouds, foundation model companies, AI-native enterprises, and more.

“5C is positioned to play a pivotal role in the AI revolution, and we are excited to welcome Brookfield as a strategic partner in our journey,” said Jonathan Ahdoot, Chief Executive Officer of 5C. “With this investment, we will accelerate the deployment of next-generation AI factories, delivering scalable infrastructure that can meet the needs of AI-driven industries. We look forward to working with Brookfield to drive the future of AI at scale and with speed.”

“5C is exceptionally well-positioned to capitalize on the next wave of infrastructure needs driven by AI,” said Hamish Kidd, Managing Director in Brookfield’s Infrastructure business. “We’re excited to support the company’s growth, and partner with its outstanding leadership team, to scale its platform across key markets.”

Fred Rosenberg, Head of U.S. Private Credit & Infrastructure at Deutsche Bank, said, “Digital infrastructure lending is critically important in today’s environment. Our partnership with 5C Group reflects a long and fruitful relationship, and our shared commitment to driving innovation and supporting the next generation of digital infrastructure and AI.”

Moelis & Company LLC acted as financial advisor and placement agent to 5C, with Osler, Hoskin & Harcourt LLP serving as its legal counsel. Simpson, Thacher & Bartlett LLP served as legal counsel to Brookfield. Milbank LLP served as legal counsel to Deutsche Bank.

About 5C

5C Group is a next-generation AI Digital Infrastructure provider established from the acquisition of 5C Data Centers by Hypertec Cloud. With over 2 gigawatts (GW) of roadmap capacity and the ability to power hundreds of thousands of GPUs, 5C Group delivers secure, reliable, and sustainable data center and AI infrastructure solutions at scale for the largest AI users with the most demanding workloads. For more information, visit www.5c.ai.

About Brookfield Asset Management

Brookfield Asset Management is a leading global alternative asset manager, headquartered in New York, with over $1 trillion of assets under management across renewable power and transition, infrastructure, private equity, real estate, and credit. Brookfield Asset Management invests client capital for the long term with a focus on real assets and essential service businesses that form the backbone of the global economy. Brookfield Asset Management offers a range of alternative investment products to investors around the world — including public and private pension plans, endowments and foundations, sovereign wealth funds, financial institutions, insurance companies, and private wealth investors. Brookfield Asset Management draws on Brookfield’s heritage as an owner and operator to invest for value and generate strong returns for its clients, across economic cycles.

About Deutsche Bank

Deutsche Bank provides retail and private banking, corporate and transaction banking, lending, asset and wealth management products and services as well as focused investment banking to private individuals, small and medium-sized companies, corporations, governments and institutional investors. Deutsche Bank is the leading bank in Germany with strong European roots and a global network.

SOURCE 5C Group

Dash’s Fully Automated Bioanalysis Platform Is Reshaping Drug Development with Speed, Precision, and Scale

NEWTON, Mass., July 23, 2025 — Dash Bio, a preclinical and clinical bioanalysis company reinventing the speed and scalability of drug development, today announced it has raised an additional $11 million in funding, bringing its total raised to $17.5 million. The new financing was led by The Aligned Fund, with participation from Freestyle Capital, Cybernetix Ventures, Swift Ventures, LifeX Ventures, Drive Capital, and others.

Dash Bio’s mission is bold but urgent: to rebuild drug development for a modern biotech era. While drug discovery has seen massive innovation through AI, mRNA, and CRISPR, drug development — the 7–12 year, multi-billion-dollar black hole between discovery and approval — remains stuck in a slow, expensive, and highly manual past. Over 70% of development work is outsourced to CROs whose labor-intensive service models are misaligned with the industry’s need for speed.

Dash Bio is tackling this bottleneck head-on. The company has built the first highly automated, GLP-compliant bioanalysis lab purpose-built to eliminate the friction of traditional CROs. Dash delivers assays like ELISA, LC-MS, and qPCR at speeds up to 10x faster than current providers — helping drug developers move from idea to IND to approval faster than ever before.

“We founded Dash because the broken state of development is one of the biggest threats to progress in biotech,” said Dave Johnson, co-founder and CEO of Dash Bio and former Chief Data & AI Officer at Moderna. “Our platform was designed the right way from day one: real automation, real integration, and real science. This funding is a strong signal that the industry is ready to embrace a new standard — one where bioanalysis is a catalyst, not a constraint.”

The company’s approach is resonating. Since its initial raise, Dash has added top-tier biopharma companies as customers and assembled a powerhouse team including former colleagues from Moderna, Science Exchange, Rootpath, and other trailblazers. With deep expertise in bioanalysis, software engineering, and lab automation, the team is uniquely positioned to bring industrial-grade efficiency to drug development.

“Dash Bio isn’t just faster — it’s foundational,” said Ariel Winton-Jones, Partner at The Aligned Fund. “Their team has built the kind of tech-forward infrastructure that biotech has needed for years. We believe Dash is creating the modern stack for bioanalysis and beyond.”

With this funding, Dash Bio will continue scaling its automated platform, expanding its assay menu, investing in its proprietary sample and assay management software, and onboarding new customers from preclinical through late-stage clinical development.

About Dash Bio
Dash Bio accelerates clinical development by delivering high-quality, technology-driven bioanalysis at unprecedented speed. Its fully automated, GLP-compliant lab platform combines robotics, AI, and integrated software to deliver faster results and better data — helping biopharma teams get therapies to patients faster. Learn more at www.dash.bio.

SOURCE Dash Bio